BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shirai Y, Sakata J, Wakai T, Ohashi T, Hatakeyama K. "Extended" radical cholecystectomy for gallbladder cancer: Long-term outcomes, indications and limitations. World J Gastroenterol 2012; 18(34): 4736-4743 [PMID: 23002343 DOI: 10.3748/wjg.v18.i34.4736] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Tan H, Liu X, Huang J, Liu L, Si S, Sun Y, Zhou W, Yang Z. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013). Cancer Med 2020;9:3668-79. [PMID: 32233076 DOI: 10.1002/cam4.2989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gonzalez SP, Wachtel MS, Onkendi EO. Operative Management of T1b Gallbladder Carcinoma with Concurrent Hepatic Anastomosing Hemangioma. Cureus 2019;11:e5081. [PMID: 31516790 DOI: 10.7759/cureus.5081] [Reference Citation Analysis]
3 Sakata J, Kobayashi T, Ohashi T, Hirose Y, Takano K, Takizawa K, Miura K, Ishikawa H, Toge K, Yuza K, Soma D, Ando T, Wakai T. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection? European Journal of Surgical Oncology (EJSO) 2017;43:780-7. [DOI: 10.1016/j.ejso.2017.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 AlMasri S, Nassour I, Tohme S, Adam MA, Hoehn RS, Bartlett DL, Lee KK, Zureikat AH, Paniccia A. Long-term survival following minimally invasive extended cholecystectomy for gallbladder cancer: A 7-year experience from the National Cancer Database. J Surg Oncol 2020. [PMID: 32531820 DOI: 10.1002/jso.26062] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Toge K, Sakata J, Hirose Y, Yuza K, Ando T, Soma D, Katada T, Miura K, Takizawa K, Kobayashi T, Wakai T. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location. Eur J Surg Oncol 2019;45:1446-52. [PMID: 30962045 DOI: 10.1016/j.ejso.2019.03.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
6 Sakata J, Kobayashi T, Tajima Y, Ohashi T, Hirose Y, Takano K, Takizawa K, Miura K, Wakai T. Relevance of Dissection of the Posterior Superior Pancreaticoduodenal Lymph Nodes in Gallbladder Carcinoma. Ann Surg Oncol 2017;24:2474-81. [PMID: 28653160 DOI: 10.1245/s10434-017-5939-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
7 Yu TN, Shen B, Meng N, Yu H, Cai XJ. Risk factors of lymphatic metastasis complement poor radiological detection in gallbladder cancer. World J Gastroenterol 2014; 20(1): 290-295 [PMID: 24415884 DOI: 10.3748/wjg.v20.i1.290] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Min JH, Kang TW, Cha DI, Kim SH, Shin KS, Lee JE, Jang K, Ahn SH. Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer. Eur Radiol 2019;29:411-21. [DOI: 10.1007/s00330-018-5602-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Jung W, Jang JY, Kang MJ, Chang YR, Shin YC, Chang J, Kim SW. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer. Gut Liver 2016;10:140-6. [PMID: 26347513 DOI: 10.5009/gnl15080] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
10 Coppola S, Masutti M, Castello G, Ferrara D, Longoni M. When diagnosis of abdominal upper right quadrant pain remains difficult and treatment even worse. Chirurgia 2021;34. [DOI: 10.23736/s0394-9508.20.05118-9] [Reference Citation Analysis]
11 Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol 2020;122:176-82. [PMID: 32383268 DOI: 10.1002/jso.25907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Riechelmann R, Coutinho AK, Weschenfelder RF, Andrade DE Paulo G, Fernandes Gdos S, Gifoni M, Oliveira Mde L, Gansl R, Gil R, Luersen G, Lucas L, Reisner M, Vieira FM, Machado MA, Murad A, Osvaldt A, Brandão M, Carvalho E, Souza T, Pfiffer T, Prolla G. GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP. Arq Gastroenterol 2016;53:5-9. [PMID: 27276097 DOI: 10.1590/S0004-28032016000100003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Gavriilidis P, Askari A, Azoulay D. To Resect or Not to Resect Extrahepatic Bile Duct in Gallbladder Cancer? J Clin Med Res 2017;9:81-91. [PMID: 28090223 DOI: 10.14740/jocmr2804w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ren X, Jiang H, Sun K, Qin X, Qu Y, Xia T, Chen Y. Mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder: case report and literature review. Diagn Pathol 2022;17:51. [PMID: 35715834 DOI: 10.1186/s13000-022-01231-6] [Reference Citation Analysis]
15 Sheka AC, Altman A, Marmor S, Hui JYC, Denbo JW, Ankeny JS, Jensen EH. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States. Surg Oncol 2020;34:298-303. [PMID: 32891346 DOI: 10.1016/j.suronc.2020.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Navarro JG, Kang I, Hwang HK, Yoon DS, Lee WJ, Kang CM. Oncologic safety of laparoscopic radical cholecystectomy in pT2 gallbladder cancer: A propensity score matching analysis compared to open approach. Medicine (Baltimore) 2020;99:e20039. [PMID: 32443308 DOI: 10.1097/MD.0000000000020039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 He XD, Li JJ, Liu W, Qu Q, Hong T, Xu XQ, Li BL, Wang Y, Zhao HT. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer. World J Gastroenterol 2015; 21(15): 4620-4626 [PMID: 25914471 DOI: 10.3748/wjg.v21.i15.4620] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Toyonaga H, Hayashi T, Ueki H, Chikugo K, Ishii T, Nasuno H, Kin T, Takahashi K, Takada M, Ambo Y, Shinohara T, Yamazaki H, Katanuma A. An intact boundary between the tumor and inner hypoechoic layer discriminates T1 lesions among sessile elevated gallbladder cancers. J Hepatobiliary Pancreat Sci 2021. [PMID: 33826798 DOI: 10.1002/jhbp.961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nigri G, Berardi G, Mattana C, Mangogna L, Petrucciani N, Sagnotta A, Aurello P, D'Angelo F, Ramacciato G. Routine extra-hepatic bile duct resection in gallbladder cancer patients without bile duct infiltration: A systematic review. Surgeon. 2016;14:337-344. [PMID: 27395014 DOI: 10.1016/j.surge.2016.06.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kakaei F, Beheshtirouy S, Nejatollahi SM, Zarrintan S, Mafi MR. Surgical treatment of gallbladder carcinoma: a critical review. Updates Surg 2015;67:339-51. [PMID: 26563387 DOI: 10.1007/s13304-015-0328-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
21 Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, Samra J, de Reuver PR, Hugh TJ. Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg 2021;91:603-8. [PMID: 33604992 DOI: 10.1111/ans.16663] [Reference Citation Analysis]
22 Jin LX, Pitt SC, Hall BL, Pitt HA. Aggressive surgical management of gallbladder cancer: at what cost? Surgery. 2013;154:266-273. [PMID: 23830031 DOI: 10.1016/j.surg.2013.04.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kamada Y, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Tani M, Sato A, Tani R, Aoyama R, Sasaki Y, Zaima M. Surgical treatment of gallbladder cancer: An eight-year experience in a single center. World J Hepatol 2020; 12(9): 641-660 [PMID: 33033570 DOI: 10.4254/wjh.v12.i9.641] [Reference Citation Analysis]